Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services reported Q2 revenue of $351.8 million, up 2% year-over-year, and raised its full-year 2026 guidance despite headwinds from IRA-related pricing reductions. Adjusted EBITDA increased 19% to $29.7 million, and the company ended the quarter with $89.8 million in cash and no long-term debt.
Key figures
- Eps
- 0.34
- Revenue
- $351.8 million
- Guidance
- FY 2026 revenue $1.43B-$1.45B (raised from $1.40B-$1.42B); Adjusted EBITDA $129M-$131M (raised from $122M-$127M)
- Revenue Yoy
- 2%
- Net income
- $22.1 million
- Adjusted eps
- 0.29
- Adjusted ebitda
- $29.7 million
- Cash equivalents
- $89.8 million
- Residents served
- 210000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.